Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.
Open Access
- 1 July 1995
- Vol. 50 (7) , 750-754
- https://doi.org/10.1136/thx.50.7.750
Abstract
BACKGROUND: The consequences of chronic obstructive pulmonary disease (COPD) on daily life, encapsulated by the term "health-related quality of life" (HRQL), are important in determining appropriate home care. There is a need to understand the relative contribution of respiratory impairment, physical disability, coping, age, and socioeconomic variables on HRQL. METHODS: Patients with COPD were recruited on admission to a pulmonary rehabilitation centre. Respiratory impairment was assessed by lung function tests and physical disability was evaluated by a 12 minute walking test. HRQL was assessed by means of the St George's Respiratory Questionnaire (SGRQ) measuring "symptoms", "activity", and "impact". Because the SGRQ does not include a measure of "well being", this was taken from the medical psychological questionnaire for lung diseases. The COPD coping questionnaire and a questionnaire covering basic socioeconomic variables were also used. RESULTS: One hundred and twenty six patients of mean (SD) age 65 (9) years and mean (SD) forced expiratory volume in one second (FEV1) 39 (9)% predicted were included. The scores on the SGRQ indicated severe impairment. Correlations were found between lung function parameters, 12 minute walking test, and the HRQL "activity" and "impact" components. Coping strategies were correlated with the "activity", "impact", and "well being" components. No correlations were found between age, socioeconomic variables, and HRQL. FEV1, 12 minute walking test, and the coping strategies "avoidance" and "emotional reaction" were the best predictors of HRQL. CONCLUSION: In patients with COPD methods of improving physical performance and teaching adequate coping strategies should be considered in order to improve HRQL.Keywords
This publication has 15 references indexed in Scilit:
- Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.Thorax, 1993
- Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease — a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 μg) with salmeterol (50 μg)Respiratory Medicine, 1992
- The effect of inhaled terbutaline on FEV1, FVC, dyspnoea and walking distance in patients with chronic obstructive lung diseaseRespiratory Medicine, 1992
- Reversibility tests in chronic obstructive airways disease: their predictive value with reference to benefit from domiciliary nebuliser therapyRespiratory Medicine, 1991
- Bronchodilator treatment for partially reversible chronic obstructive airways disease.Thorax, 1991
- Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.Thorax, 1988
- Comparison of Clinical Dyspnea Ratings and Psychophysical Measurements of Respiratory Sensation in Obstructive Airway Disease1–4American Review of Respiratory Disease, 1987
- Accuracy of Pulmonary Function Tests in Predicting Exercise Tolerance in Chronic Obstructive Pulmonary DiseaseChest, 1984
- Dose‐response curves to inhaled beta‐adrenoceptor agonists in normal and asthmatic subjects.British Journal of Clinical Pharmacology, 1983
- Dose-response study of inhaled salbutamol powder in chronic airflow obstruction.Thorax, 1983